A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non-muscle-invasive Bladder Cancer

Benjamin Lichtbroun; Arnav Srivastava; Saum Ghodoussipour

doi:10.1016/j.euf.2023.05.010

A Restaging Transurethral Resection of Bladder Tumor Is Always Necessary For High-grade T1 Non-muscle-invasive Bladder Cancer

Eur Urol Focus. 2023 Jul;9(4):557-558. doi: 10.1016/j.euf.2023.05.010. Epub 2023 Jun 1.

Authors

Benjamin Lichtbroun¹, Arnav Srivastava¹, Saum Ghodoussipour²

Affiliations

¹ Section of Urologic Oncology, Division of Urology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ, USA.
² Section of Urologic Oncology, Division of Urology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson University Hospital, New Brunswick, NJ, USA. Electronic address: saum.ghodoussipour@rutgers.edu.

PMID: 37270358
DOI: 10.1016/j.euf.2023.05.010

Abstract

Patients with high-grade T1 non-muscle-invasive bladder cancer (NMIBC) have a high risk of recurrence and upstaging. Restaging transurethral resection of bladder tumor allows better staging so that patients can proceed to the appropriate treatment in a timely manner. This should be done in all patients with high-grade T1 NMIBC.

MeSH terms

Humans
Neoplasm Staging
Non-Muscle Invasive Bladder Neoplasms*
Transurethral Resection of Bladder
Urinary Bladder Neoplasms* / pathology
Urinary Bladder Neoplasms* / surgery
Urologic Surgical Procedures